| INTRODUCTION
Over the last decade, there has been a shift in the geographic patterns of intravenous drug use (IVDU) in the United States from focal urban locations to rural areas. 1, 2 There are various socioeconomic factors that have influenced these patterns alongside more liberal opioid prescription practices. 3 The shifting burden of IVDU to more rural areas has created unique challenges for patient access (medical attention, addiction education, and rehabilitation), as well as an avalanche of additional costs for hospitals located within the endemic areas. Coinciding with the escalation of drug-related socioeconomic burden, the rural hospitals, and tertiary referral centers in Appalachia are caring for an increasing density of uninsured and underinsured patients. 4, 5 In addition, poor sterile technique used by IVDUs and immune compromise from dietary deficiencies in drug abusers has caused an increase of hepatitis C and other related illnesses with dramatic loss of productivity, reduced long-term quality of life, and increased healthcare costs. 6, 7 The Appalachian syndemic of the opioid crisis, worsening hepatitis C, recent human immunodeficiency virus (HIV) outbreak and economic challenges is punctuated by recent data suggesting West
Virginia now leads the nation in mortality from drug overdoses (35.5 deaths per 100 000). 1 It is well known that poor sterile technique and repeated interruption of the skin/blood barrier have been implicated in IVDU associated infective endocarditis (IE) (IVDU-IE) that most frequently involves the tricuspid valve. 8 In addition, the use of unsterilized needles, bacteria in the injectate (drug, diluents, and fillers), can result in the introduction of bacteria or fungi directly into the bloodstream. These patients are also prone to developing immune compromise because of associated hepatitis, poor nutrition, and poor dentition. IVDUs also have higher rates of nasal and cutaneous colonization with Staphylococcus aureus than patients who use illicit drugs by the oral route exclusively. 9 S. aureus is the most common infectious agent in these patients and IE is on the rise within the United States. 10 Studies have analyzed differences in the effect of drug abuse on endocarditis, such as age, outcome, healthcare cost, and the patterns of geographical abuse. 11 It is clear that IVDUs are at an increased risk for IE, have a higher incidence of recurrent IE and higher expected mortality than those who develop IE without associated drug addiction. 12 These patients often require high-acuity hospital resources and prolonged intensive care. 9 There are also long recovery times from valve surgery, if needed. In addition, IVDUs-IE often seek delayed medical attention which poses significant challenges to emergency departments and front-line physicians. 11 At the same time that collateral healthcare costs from the drug epidemic have been increasing, the economic downturn, and contraction of revenue from the energy sector have negatively impacted the rural healthcare systems in Appalachia amplifying the economic impact on hospitals and healthcare providers. 13, 14 The crisis created by the collision of rural economic instability and the drug epidemic in Appalachia has stimulated much discussion on needed policy reform. [13] [14] [15] [16] [17] [18] Our center is the largest cardiovascular tertiary referral center in southern West Virginia and resides in the epicenter of the Appalachian opiate epidemic and energy sector decline associated economic collapse. The center has seen alarming increases in IE and we hypothesized that this was due to increases in IVDU-IE. Since IE is often very difficult to treat and consumes significant hospital resources, we set out to quantify changes in IE hospitalization patterns and associated costs in southern West Virginia. The data variables obtained from the CAMC database included:
Number of cases of patients hospitalized with IVDU and IE and patient variables including time of hospitalization, Zip codes, type of drug use (opiates, cocaine, amphetamines, sedatives, and mixed drug use), gender, age, race, and insurance status. Primary payers were identified by federal, state, and private payers and the study further subdivided all primary payers. We obtained detailed analysis of hospital charges to better understand the current annual economic burden for our center and federal/state funding agencies.
| STATISTICAL ANALYSIS
We analysis this attempts to screen out potential non-cases.
| RESULTS
The demographics of the study population are shown in Table 1 .
Through the years there was a significant increase in admissions with any type of drug use as well as associated endocarditis as illustrated in Table 2 . Increases in mixed drug use strongly correlated with increased cases of IE during the study period (P = 0.001). This suggests that for every 100 cases of mixed drug use there is a 0.06% increase in relative risk of endocarditis. This strong relationship can further be investigated with a time series line graph to illustrate this visual relationship over the same time period Figure 1 . As shown within the time series line plot graph, endocarditis drug patients with mixed drug use have an almost mirrored relationship and most of the drug use related endocarditis nearing the end of the study was in the mixed drug use category.
The overall state health metric variable of household income was not significantly associated with the increase in endocarditis (P = 0.176). The payer mix for the study cohort is detailed in Table 3 alongside all the hospital charges vs the actual payment received. Pri- of $700 million in the United States. 23, 24 It should be noted that the increase in IVDU-IE is not isolated to Appalachia with less dramatic trends also reported in differing regions of the country.
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The average charges for our IVDU-IE patients in the last year of the study (approximately $70 000/patient) are well below the national average of $120 000 and may reflect our team's attempts to avoid open heart surgery since IVDU-IE patients are 10 times more likely to die or need a second surgery. 16, 28 This study has many limitations. First, in our center, the diagnosis of "mixed drug use" strongly correlates with IV drug use but it is not definitive. We elected to use this DRG since often these patients deny IVDU and clear objective clinical signs are often lacking. Also, the use of hospital ICD9/10 codes to establish a diagnosis is associated with several known limitations. Thus, the findings must be considered in that context. As a countermeasure for these limitations, patient data and drug use data were combined to filter out other cases of endocarditis that did not appear to have a drug-related cause. This approach allows for multiple filters to view the relationship that is occurring in the region; unfortunately, this method may under report certain cases.
We acknowledge these limitations and accordingly describe the findings as associations without concluding causation. Also, the review of 
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Further research is needed to understand the overall impact of illicit drug use in the region and the multiple socioeconomic issues or other causation variables that may be participating in the epidemic.
However, based on the findings reported herein, investment in resources for high-risk areas, defined by geo-map driven hot spot analysis, for needle exchanges and rehabilitation centers may be warranted. Along those lines, we are now seeking to define clusters or regions with increased serious infection risk so we can study the impact of local interventions and hopefully translate these findings into preventive solutions.
